Insulin Glargine Dose and Weight Changes in Underweight, Normal Weight, and Overweight Children Newly Diagnosed with Type 1 Diabetes Mellitus-Reference-Cited by-同舟云学术

Insulin Glargine Dose and Weight Changes in Underweight, Normal Weight, and Overweight Children Newly Diagnosed with Type 1 Diabetes Mellitus

Published:2019-06-06 Issue:7 Volume:39 Page:741-748
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Chalk Bethany Sharpless¹^ORCID,Crane Janet²,Yenokyan Gayane³,Pineda Erika May⁴,Lee Carlton K.K.¹²

Affiliation:

1. Department of Pharmacy The Johns Hopkins Hospital Baltimore Maryland

2. Department of Pediatrics Johns Hopkins University School of Medicine Baltimore Maryland

3. Johns Hopkins Biostatistics Center Johns Hopkins Bloomberg School of Public Health Baltimore Maryland

4. University of Maryland School of Pharmacy Baltimore Maryland

Funder

National Center for Research Resources

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2281

Reference16 articles.

1. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association

2. Impact of the Diabetes Canada Guideline Dissemination Strategy on the Prescription of Vascular Protective Medications: A Retrospective Cohort Study, 2010–2015

3. Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes

4. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy.

5. Statistics About Diabetes. American Diabetes Association 2018. Available fromhttp://www.diabetes.org/diabetes-basics/statistics/. Accessed April 3 2019.